About Relation Therapeutics
Relation Therapeutics is a company based in London (United Kingdom) founded in 2020 by Benjamin Swerner.. Relation Therapeutics has raised $116.43 million across 5 funding rounds from investors including Nvidia, Khosla Ventures and GSK. The company has 12 employees as of November 30, 2020. Relation Therapeutics offers products and services including Lab-in-the-Loop. Relation Therapeutics operates in a competitive market with competitors including DNAnexus, Cytel, Metagenomi, Ampersand and Octant, among others.
- Headquarter London, United Kingdom
- Employees 12 as on 30 Nov, 2020
- Founders Benjamin Swerner
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Relation Therapeutics Limited
- Date of Incorporation 08 Nov, 2019
- Jurisdiction LONDON, UNITED KINGDOM
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$116.43 M (USD)
in 5 rounds
-
Latest Funding Round
$36.18 M (USD), Seed
Nov 21, 2025
-
Investors
Nvidia
& 10 more
-
Employee Count
12
as on Nov 30, 2020
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Relation Therapeutics
Relation Therapeutics offers a comprehensive portfolio of products and services, including Lab-in-the-Loop. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Integrates single-cell analysis and machine learning for advancing medicines
Unlock access to complete
Unlock access to complete
Funding Insights of Relation Therapeutics
Relation Therapeutics has successfully raised a total of $116.43M across 5 strategic funding rounds. The most recent funding activity was a Seed round of $36.18 million completed in November 2025. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 5
- Last Round Seed — $36.2M
-
First Round
First Round
(10 Aug 2021)
- Investors Count 11
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov, 2025 | Amount | Seed - Relation Therapeutics | Valuation |
investors |
|
| Nov, 2024 | Amount | Seed - Relation Therapeutics | Valuation |
investors |
|
| Jan, 2024 | Amount | Seed - Relation Therapeutics | Valuation | DCVC , nVentures |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Relation Therapeutics
Relation Therapeutics has secured backing from 11 investors, including institutional, venture fund, and angel investors. Prominent investors backing the company include Nvidia, Khosla Ventures and GSK. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital firm focused on multiple sectors
|
Founded Year | Domain | Location | |
|
Venture capital firm focused on deep tech, fintech, and AI companies
|
Founded Year | Domain | Location | |
|
Magnetic Ventures is focused on transforming healthcare through AI and biotech investments.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Relation Therapeutics
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Relation Therapeutics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Relation Therapeutics Comparisons
Competitors of Relation Therapeutics
Relation Therapeutics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as DNAnexus, Cytel, Metagenomi, Ampersand and Octant, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Cloud-based genome informatics and data management are provided.
|
|
| domain | founded_year | HQ Location |
Data analysis and statistical solutions are provided for life sciences.
|
|
| domain | founded_year | HQ Location |
Next-generation gene editing tools are developed for drug enhancement.
|
|
| domain | founded_year | HQ Location |
Programmable medicines are developed to target and treat multiple diseases.
|
|
| domain | founded_year | HQ Location |
Human cell interaction platform is provided for drug discovery.
|
|
| domain | founded_year | HQ Location |
Bioinformatics platform for precision medicine development is offered.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Relation Therapeutics
Frequently Asked Questions about Relation Therapeutics
When was Relation Therapeutics founded?
Relation Therapeutics was founded in 2020 and raised its 1st funding round 1 year after it was founded.
Where is Relation Therapeutics located?
Relation Therapeutics is headquartered in London, United Kingdom. It is registered at London, England, United Kingdom.
Who is the current CEO of Relation Therapeutics?
David Roblin is the current CEO of Relation Therapeutics.
Is Relation Therapeutics a funded company?
Relation Therapeutics is a funded company, having raised a total of $116.43M across 5 funding rounds to date. The company's 1st funding round was a Seed of $40.25M, raised on Aug 10, 2021.
How many employees does Relation Therapeutics have?
As of Nov 30, 2020, the latest employee count at Relation Therapeutics is 12.
What does Relation Therapeutics do?
Relation Therapeutics was founded in 2020 and is based in London, United Kingdom. Operations focus on the biotechnology sector, where software platforms for target and drug discovery are developed. Human genetics, single-cell omics, and perturbational data are leveraged by the platform to support genetic disease management. Tools are designed for use by researchers in advancing therapeutic development.
Who are the top competitors of Relation Therapeutics?
Relation Therapeutics's top competitors include DNAnexus, Cytel and Metagenomi.
What products or services does Relation Therapeutics offer?
Relation Therapeutics offers Lab-in-the-Loop.
Who are Relation Therapeutics's investors?
Relation Therapeutics has 11 investors. Key investors include Nvidia, Khosla Ventures, GSK, ARK Investment Management, and DCVC.